These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6119805)

  • 1. Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivo.
    Molineaux CJ; Batzinger RP; Schmidt W; Bueding E
    Teratog Carcinog Mutagen; 1980; 1(2):129-39. PubMed ID: 6119805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinus.
    Reddy BS; Batzinger RP; Molineaux CJ; Bueding E
    Antimicrob Agents Chemother; 1982 Oct; 22(4):707-8. PubMed ID: 7181482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the mutagenic activation of an antischistosomal isothiocyanate in primates by an antibiotic.
    Batzinger RP; Bueding E; Crawford K; Bruce J
    Environ Mutagen; 1979; 1(4):353-60. PubMed ID: 553807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the elimination of nithiocyamine from patients with schistosomiasis and its toxicities to the liver-bile system of rats].
    Liu CX; Huang WT; Liu RF; Ye GZ; Xiang JJ; Zhang ZL; Hu JC
    Yao Xue Xue Bao; 1983 Feb; 18(2):86-9. PubMed ID: 6613597
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of a mutagenic drug metabolite by intestinal microorganisms.
    Batzinger RP; Bueding E; Reddy BS; Weisburger JH
    Cancer Res; 1978 Mar; 38(3):608-12. PubMed ID: 414832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of amoscanate against experimental schistosomal infections in monkeys.
    Crawford KA; Asch HL; Bruce JI; Bueding E; Smith ER
    Am J Trop Med Hyg; 1983 Sep; 32(5):1055-64. PubMed ID: 6625061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by antibiotics against experimental focal cholangitis produced in mice by a schistosomicidal isothiocyanate.
    Batzinger RP; Bueding E; Popper H
    Hepatology; 1981; 1(1):21-7. PubMed ID: 7286888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of sulfoscanate: a comparative study.
    Juneja TR; Talukdar A; Gupta RL
    Mutat Res; 2002 Jul; 518(2):155-61. PubMed ID: 12113767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of the antischistosomal agent amoscanate administered in high oral doses to rats.
    Clark AW; Kiel SM; Parhad IM
    Neurotoxicology; 1982 Nov; 3(3):1-11. PubMed ID: 6891757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune response to a schistosomacide, amoscanate. I. Serum antibody responses.
    Barton BE; Levy DA
    J Immunopharmacol; 1985; 7(3):343-71. PubMed ID: 2414366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the antischistosomal action and toxicity of phenyl 4-nitro-diphenylamino-4'-thioncarbamate (7720)].
    Quan YZ; Huang WY; Zhou QX; Li YZ
    Yao Xue Xue Bao; 1982 Jul; 17(7):481-6. PubMed ID: 7180477
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioimmunoassay for an antischistosomal drug, 4-nitro-4'-isothiocyano-diphenylamine (7505) (author's transl)].
    Wang ZT; Wang DN; Li Q; Ouyang HJ
    Yao Xue Xue Bao; 1980 Aug; 15(8):463-9. PubMed ID: 7211390
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in antischistosomal and mutagenic properties between an isothiocyano- and an isocyanonitrodiphenylamine.
    Coulter AW; Bueding E; Batzinger RP
    J Med Chem; 1977 Jul; 20(7):981-2. PubMed ID: 327069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the hepatotoxic effect of nithiocyaminum. II. Human biopsy and animal experiment (author's transl)].
    Miao DL
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):475-8. PubMed ID: 7338081
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents.
    Batzinger RP; Ou SY; Bueding E
    Cancer Res; 1978 Dec; 38(12):4478-85. PubMed ID: 363261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to a schistosomacide, amoscanate. II. Cell-mediated immune responses.
    Barton BE; Levy DA
    J Immunopharmacol; 1985; 7(3):373-83. PubMed ID: 4056413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the DNA-repair host-mediated assay for determining the organ distribution of genotoxic factors in mice treated orally with nitro-aromatic compounds.
    Knasmüller S; Kerklaan P; Mohn GR
    Mutat Res; 1986 Feb; 164(1):9-17. PubMed ID: 2419751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540).
    Bueding E; Batzinger R; Petterson G
    Experientia; 1976 May; 32(5):604-6. PubMed ID: 1278309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of amoscanate derivatives in experimental schistosomiasis].
    Yue WJ; Shao BR; Pan QR; You JQ; Mei JY
    Yao Xue Xue Bao; 1983 Jul; 18(7):541-4. PubMed ID: 6659959
    [No Abstract]   [Full Text] [Related]  

  • 20. Early effects of high-dosed absorbable amoscanate on rat brain.
    Krinke G; Graepel P; Krueger L; Thomann P
    Toxicol Lett; 1983 Dec; 19(3):261-6. PubMed ID: 6658839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.